Natallia Barreiros de Natividade Paulo Antonio Oldani Felix Claudio Lerer
10.1590/abd1806-4841.20175871
An Bras Dermatol
2017;92(5 Suppl 1):85-87.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29267456/
Adalimumab / adverse effects Anti-Inflammatory Agents / adverse effects Guillain-Barre Syndrome / chemically induced Psoriasis / drug therapy Tumor Necrosis Factor-alpha / antagonists & inhibitors
Adalimumab / adverse effects Anti-Inflammatory Agents / adverse effects Guillain-Barre Syndrome / chemically induced Psoriasis / drug therapy Tumor Necrosis Factor-alpha / antagonists & inhibitors Case Reports Humans Male Middle Aged Psoriasis / complications Treatment Outcome Anti-Inflammatory Agents Tumor Necrosis Factor-alpha Adalimumab
PMC5726687
29267456
Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
2017